First-Line Nivolumab Plus Ipilimumab With Chemotherapy for Metastatic NSCLC: The Updated Outcomes From CheckMate 9LA. Zhao B, Ma W. J Thorac Oncol 2023;18:e101-e102.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Zhao B, Ma W. First-Line Nivolumab Plus Ipilimumab With Chemotherapy for Metastatic NSCLC: The Updated Outcomes From CheckMate 9LA. J Thorac Oncol 2023;18:e101-e102.
PMID: 37599048